logo
Share SHARE
FONT-SIZE Plus   Neg

Tissue Regenix Launches DermaPure In US; Stock Climbs

Shares of Tissue Regenix Group Plc (TRX.L) climbed around 18 percent in the morning trading in London after the British regenerative medical devices company announced that it has launched DermaPure, its decellularised dermis product, in the US.

Tissue Regenix's partner Community Tissue Services or CTS will begin shipping product to customers next week.

DermaPure is initially being targeted at acute care patients with diabetic foot ulcers. The company noted that the commercial launch of the DermaPure dermis allograft will now allow Tissue Regenix to target a market worth $1.4 billion a year for wound healing devices and equipment.

Tissue Regenix said its DermaPure works by taking human donor skin and removing the DNA and cells, using the patented dCELL process to leave a natural biological scaffold that can be placed in the wound to aid natural healing by attracting the patient's own cells to the wound area.

Tissue Regenix noted that its patented decellularisation or dCELL technology removes DNA and other cellular material from animal and human tissue leaving an acellular.

In addition to the launch of DermaPure, the company announced that it has continued to expand its distribution network around the country and currently has a network of over 60 reps that covers 80 percent of the US.

In addition, Tissue Regenix has signed an exclusive government supplier partnership with TASSMA for the distribution of DermaPure. The partnership with TASSMA will allow Tissue Regenix to immediately target the Department of Veteran's Affairs Healthcare System and the numerous branches of the US military, the company noted.

Greg Bila, President of Tissue Regenix Wound Care Inc. said, "Commercial production and distribution of the DermaPure is a significant step forward for Tissue Regenix. This paves the way for the development of other human tissue based medical treatments." In London, Tissue Regenix shares are currently trading at 24.15 pence, up 3.65 pence or 17.80 percent.

by RTT Staff Writer

For comments and feedback: editorial@rttnews.com

Business News

Quick Facts

Editors Pick
Burger chain Shake Shack Inc. said late Thursday that it has priced its initial public offering of 5 million Class A shares at $21 per share, which is above the previously estimated price range of $17 to $19 per share. The shares are expected to begin trading on the New York Stock Exchange on Friday, January 30 under the ticker symbol "SHAK." Google reported a higher fourth-quarter profit, driven by a 15 percent increase in revenues and one-time gains from the sale of Motorola Mobile business, somewhat offset by stock-based compensation expense and foreign exchange losses. Quarterly earnings and revenue missed Wall Street estimates, as ad revenues came under pressure. Online retailer Amazon.com, Inc. said Thursday after the markets closed that its fourth quarter fell 10.5% from last year, as higher expenses more than offset a 15% increase in sales. However, the company's quarterly earnings per share came in well above analysts' expectation, but its quarterly sales fell short of analysts' forecast.
comments powered by Disqus
Follow RTT